ATE453725T1 - Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen - Google Patents

Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen

Info

Publication number
ATE453725T1
ATE453725T1 AT01913809T AT01913809T ATE453725T1 AT E453725 T1 ATE453725 T1 AT E453725T1 AT 01913809 T AT01913809 T AT 01913809T AT 01913809 T AT01913809 T AT 01913809T AT E453725 T1 ATE453725 T1 AT E453725T1
Authority
AT
Austria
Prior art keywords
cyp2b6
well
polynucleotides
diagnosing
vectors
Prior art date
Application number
AT01913809T
Other languages
English (en)
Inventor
Ulrich Zanger
Thomas Lang
Original Assignee
Epidauros Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidauros Biotechnologie Ag filed Critical Epidauros Biotechnologie Ag
Application granted granted Critical
Publication of ATE453725T1 publication Critical patent/ATE453725T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C12N9/0038—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01913809T 2000-02-09 2001-02-09 Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen ATE453725T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00102701 2000-02-09
PCT/EP2001/001456 WO2001059152A2 (en) 2000-02-09 2001-02-09 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications

Publications (1)

Publication Number Publication Date
ATE453725T1 true ATE453725T1 (de) 2010-01-15

Family

ID=8167810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01913809T ATE453725T1 (de) 2000-02-09 2001-02-09 Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen

Country Status (9)

Country Link
US (2) US20040224313A1 (de)
EP (1) EP1272663B1 (de)
AT (1) ATE453725T1 (de)
AU (1) AU3925701A (de)
DE (1) DE60140934D1 (de)
DK (1) DK1272663T3 (de)
ES (1) ES2338523T3 (de)
PT (1) PT1272663E (de)
WO (1) WO2001059152A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2705052B1 (de) 2011-05-05 2017-11-15 Institut National de la Sante et de la Recherche Medicale (INSERM) Cytochrom-p450-mutationen und deren verwendungen
CN115976190B (zh) * 2022-11-15 2024-08-27 苏州吉赛基因测序科技有限公司 剖宫产患者术后镇痛用药相关基因分型检测的产品及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103314D0 (en) * 1991-02-16 1991-04-03 Imp Cancer Res Tech Assay systems
CA2128399A1 (en) * 1993-07-20 1995-01-21 Koji Hayashi Method for safety evaluation of chemical compound using recombinant yeast expressing human cytochrome p450
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
US6207648B1 (en) * 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy
CN1357048A (zh) * 1998-03-06 2002-07-03 牛津生物医学（英国）有限公司 增强前体药物活化

Also Published As

Publication number Publication date
US20040224313A1 (en) 2004-11-11
WO2001059152A3 (en) 2002-10-31
PT1272663E (pt) 2010-03-01
AU3925701A (en) 2001-08-20
ES2338523T3 (es) 2010-05-10
WO2001059152A2 (en) 2001-08-16
EP1272663B1 (de) 2009-12-30
EP1272663A2 (de) 2003-01-08
WO2001059152A9 (en) 2002-08-08
DK1272663T3 (da) 2010-04-26
US20090311696A1 (en) 2009-12-17
DE60140934D1 (de) 2010-02-11

Similar Documents

Publication Publication Date Title
Apostolova et al. Associations of the top 20 Alzheimer disease risk variants with brain amyloidosis
Ross et al. Ataxin-2 repeat-length variation and neurodegeneration
Rishal et al. Axon–soma communication in neuronal injury
Zimmer-Bensch et al. DNA methylation in genetic and sporadic forms of neurodegeneration: lessons from Alzheimer’s, related tauopathies and genetic tauopathies
Visconti et al. Epigenetics of myotonic dystrophies: a minireview
Dzobo Epigenomics-guided drug development: recent advances in solving the cancer treatment “jigsaw puzzle”
ATE365798T1 (de) Mittel und verfahren zur diagnose und behandlung affektiver störungen
EE200200049A (et) Polümorfismid inimese MDR-1 geenis ning nende kasutamine diagnostikas ja terapeutilistes rakendustes
WO2001020025A3 (en) Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
de Sousa et al. Impact of oxidative DNA damage and the role of DNA glycosylases in neurological dysfunction
Møller Johansen et al. Time course of DNA methylation in pain conditions: From experimental models to humans
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
ATE440967T1 (de) Auswahl von tieren für gewünschte genotypische und potentielle phänotypische eigenschaften auf der basis eines einzelnen nukleotidpolymorphismus (snp) im intron 3 des igf2-gens
Pang et al. High-throughput sequencing offers new insights into 5-hydroxymethylcytosine
DK1656458T3 (da) Human autisme-susceptibilitetsgen og anvendelser deraf
DE60140934D1 (de) Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen
TW200724679A (en) Treatment of disease using an improved regulated expression system
SE0002189D0 (sv) New method and assay
Olsson et al. Epigenetic regulation of tissue-type plasminogen activator in human brain tissue and brain-derived cells
DE50312502D1 (de) Screeningverfahren zum identifizieren protektiver substanzen für die behandlung neurodegenerativer und/oder ischämischer erkrankungen
DE602005016676D1 (de) Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas-suszeptibilitätssgen und dessen verwendung
Bharadwaj et al. The mind and its nucleosomes—Chromatin (dys) regulation in major psychiatric disease.
DE60330565D1 (de) Anti-fragilis Antikörper und dessen Verwendungen
Holcomb et al. GRHD PLANNING COMMITTEE
SE0303268D0 (sv) Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1272663

Country of ref document: EP